These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4629252)

  • 1. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
    Bjornson AB; Michael JG
    Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.
    Bjornson AB; Michael JG
    Infect Immun; 1971 Oct; 4(4):462-7. PubMed ID: 5005303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
    Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
    J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.
    Reynolds HY; Kazmierowski JA; Newball HH
    J Clin Invest; 1975 Aug; 56(2):376-85. PubMed ID: 807599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.
    Pier GB; Thomas D; Small G; Siadak A; Zweerink H
    Infect Immun; 1989 Jan; 57(1):174-9. PubMed ID: 2491835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
    [No Abstract]   [Full Text] [Related]  

  • 8. Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.
    Young LS
    J Infect Dis; 1972 Sep; 126(3):277-87. PubMed ID: 4626510
    [No Abstract]   [Full Text] [Related]  

  • 9. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody.
    Schreiber JR; Pier GB; Grout M; Nixon K; Patawaran M
    J Infect Dis; 1991 Sep; 164(3):507-14. PubMed ID: 1831226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.
    Moody MR; Kessel RW; Young VM; Fiset P
    Infect Immun; 1978 Sep; 21(3):905-13. PubMed ID: 101467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.
    Pollack M; Koles NL; Preston MJ; Brown BJ; Pier GB
    Infect Immun; 1995 Nov; 63(11):4481-8. PubMed ID: 7591089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. II. In vitro bactericidal and opsonophagocytic studies with specific antiserum.
    Lieberman MM; Frank WJ; Brady AV
    J Surg Res; 1988 Mar; 44(3):251-8. PubMed ID: 3125389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
    Fick RB; Naegel GP; Matthay RA; Reynolds HY
    J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
    Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
    Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.